Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival

SIMPLE SUMMARY: It is known that doxorubicin is one of the standards for chemotherapy treatment against Ewing sarcoma. Despite its widespread use, doxorubicin treatment initiates tumor escape mechanisms and disease relapse. Our study aims to identify the potential biomarkers of doxorubicin resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakushov, Semyon, Menyailo, Maxim, Denisov, Evgeny, Karlina, Irina, Zainullina, Viktoria, Kirgizov, Kirill, Romantsova, Olga, Timashev, Peter, Ulasov, Ilya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688843/
https://www.ncbi.nlm.nih.gov/pubmed/36428591
http://dx.doi.org/10.3390/cancers14225498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688843/
https://www.ncbi.nlm.nih.gov/pubmed/36428591
http://dx.doi.org/10.3390/cancers14225498

Ejemplares similares